Alternative Data for Aditxt
| Alternative Data | Value | 3m Change | Trend | Benchmark | |
|---|---|---|---|---|---|
| Sentiment | 84 | Sign up | Sign up | Sign up | |
| Webpage traffic | 3,000 | Sign up | Sign up | Sign up | |
| Google Trends | N/A | Sign up | Sign up | Sign up | |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up | |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up | |
| Stocktwits Mentions | 100 | Sign up | Sign up | Sign up | |
| Stocktwits Subscribers | 15,700 | Sign up | Sign up | Sign up | |
| X Mentions | 23 | Sign up | Sign up | Sign up | |
| News Mentions | N/A | Sign up | Sign up | Sign up | |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Aditxt
None
| Price | $0.87 |
| Target Price | Sign up |
| Volume | 4,020,000 |
| Market Cap | $1.3M |
| Year Range | $0.73 - $205.66 |
| Dividend Yield | 0% |
| PE Ratio | 0 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Drop in Short InterestOctober 2 - ETF Daily News |
|
![]() |
Wall Street Set to Open Higher Wednesday as Investors Dissect Mixed Jobs Report, Look Ahead to Thursday's Inflation DataDecember 16 - Yahoo |
![]() |
Stock's 52% After‑Hours Surge?December 16 - Biztoc.com |
Correction: Comparing neutralizing antibody activity over time between naïve and convalesced COVID-19 vaccinated individualsNovember 3 - Nature.com |
|
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, BFIN, MRCC, EVFM on Behalf of ShareholdersSeptember 11 - GlobeNewswire |
|
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – EVFM, MRCC, MLNK, and BFINSeptember 11 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 750 | 68,000 | -68,000 | -24M | -24M | -548.780 |
| Q2 '25 | 1,000 | 69,000 | -68,000 | -7.3M | -6.1M | -390.170 |
| Q1 '25 | 1,000 | 730 | 280 | -5.7M | -5.5M | -8.115 |
| Q4 '24 | 3,200 | 71,000 | -68,000 | -5.2M | -5.1M | -100.700 |
| Q3 '24 | 6,900 | 470,000 | -460,000 | -6.9M | -4.6M | -111.069 |
Insider Transactions View All
| Brady Brian Michael filed to sell 3 shares at $1.8. December 19 '25 |
| HRT FINANCIAL LP filed to buy 25,434 shares at $1.5. October 17 '24 |
| BNP PARIBAS SECURITIES CORP filed to sell 22,342 shares at $33.2. September 7 '23 |
Similar companies
Read more about Aditxt (ADTX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, x mentions, news mentions & customer reviews.
FAQ - Aditxt
The Market Cap of Aditxt is $1.3M.
As of today, Aditxt 's PE (Price to Earnings) ratio is 0.
Currently, the price of one share of Aditxt stock is $0.87.
The ADTX stock price chart above provides a comprehensive visual representation of Aditxt 's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aditxt shares. Our platform offers an up-to-date ADTX stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Aditxt (ADTX) does not offer dividends to its shareholders. Investors interested in Aditxt should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Aditxt are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.






